Epirubicin (CAS-56420-45-2) Injection in dosage form. The subject product, Epirubicin Injection, is an anthracycline antibiotic belonging to a group of chemotherapy drugs. It is used in the treatment of early stage breast cancer and is typically used in combination with other drugs to prevent breast cancer cells from coming back or spreading to other parts of the body.
[1] Please importantly note that only the relevant portion of the related is displayed above. You may refer to the said customs ruling for the entire ruling explanation.
[1]. https://rulings.cbp.gov/ruling/N036237